PCDHB9 promotes resistance to bicalutamide and is associated with the survival of prostate cancer patients
@article{Sekino2019PCDHB9PR, title={PCDHB9 promotes resistance to bicalutamide and is associated with the survival of prostate cancer patients}, author={Yohei Sekino and Keisuke Goto and N. Sakamoto and N. Oue and K. Sentani and T. Hayashi and J. Teishima and A. Yasui and A. Matsubara}, journal={European Urology Supplements}, year={2019}, volume={18} }